The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Tue., Jul. 26, 3:54 PM

Slide #5. Chembio Diagnostics, Inc. Secondary Offering

Company: Chembio Diagnostics, Inc. (NASDAQ:CEMI)
Date announced: 7/25/2016
Secondary Offering Details: Chembio Diagnostics, Inc. (NASDAQ:CEMI) (the "Company") today announced that it has commenced an underwritten public offering of $10.0 million of common shares (the "Offering"). In addition, the Company intends to grant the underwriters a 30-day option to purchase additional shares equal to up to 15% of the aggregate number of shares to be sold in the Offering to cover over-allotments, if any.

Chembio Diagnostics develops, manufactures, markets and licenses point-of-care diagnostic tests that detect infectious diseases. Co.'s main products are four tests for the detection of human immunodeficiency virus (HIV) antibodies. Three of these products can be used with various blood matrices as samples, and are manufactured in a cassette format, a dipstick format, and a barrel format. Co.'s fourth rapid HIV test detects antibodies to HIV in oral fluid samples, as well as in various blood matrices. Co. also has two tests for the detection of syphilis, and a test for the detection of canine leishmaniasis.
Open the CEMI Page at The Online Investor »

Company Name:  Chembio Diagnostics Inc
Sector:  Medical Instruments & Supplies
Number of ETFs Holding CEMI:  2
Total Market Value Held by ETFs:  $196860
Total Market Capitalization:  $82.00M
% of Market Cap. Held by ETFs:  0.24%

Open the CEMI Page at The Online Investor (in a new window) »

July 26, 2016    3:54 PM Eastern
Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
83rd percentile
(ranked higher than approx. 83% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.